Spectral AI (MDAI)

• Market cap: $21M
• 1 day: -20.42%
• 5 days: -16.30%
• 1 month: -7.38%
• 3 months: -28.03%
• 6 months: -38.59%
• Year to date: -55.34%
• 1 year: -56.70%
• 5 years: -78.23%
• 10 years: -78.23%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Employees: 78

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

800% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 1

1.84% more ownership

Funds ownership: 15.68% [Q2] → 17.52% (+1.84%) [Q3]

0% more funds holding

Funds holding: 22 [Q2] → 22 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

22% less capital invested

Capital invested by funds: $4.63M [Q2] → $3.6M (-$1.03M) [Q3]